Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 402

1.

PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.

Rabban JT, McAlhany S, Lerwill MF, Grenert JP, Zaloudek CJ.

Am J Surg Pathol. 2010 Feb;34(2):137-46. doi: 10.1097/PAS.0b013e3181c89c98.

PMID:
20061933
4.

Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.

Mikami Y, Kiyokawa T, Hata S, Fujiwara K, Moriya T, Sasano H, Manabe T, Akahira J, Ito K, Tase T, Yaegashi N, Sato I, Tateno H, Naganuma H.

Mod Pathol. 2004 Aug;17(8):962-72.

5.

Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis.

Young RH, Clement PB.

Histopathology. 2002 Sep;41(3):185-207. Review.

PMID:
12207781
6.

Immunopathological study of mesonephric lesions of cervix uteri and vagina.

Kondi-Pafitis A, Kairi E, Kontogianni KI, Dimopoulou C, Sikiotis K, Smyrniotis V.

Eur J Gynaecol Oncol. 2003;24(2):154-6.

PMID:
12701967
7.
8.

Affinity of four lectins for endocervical and endometrial non-neoplastic and neoplastic glandular epithelium.

Toda T, Sadi AM, Egawa H, Atari E, Qureshi B, Nagai Y.

Histopathology. 1998 Mar;32(3):257-63.

PMID:
9568512
9.

Mitotic activity and apoptosis in endocervical glandular lesions.

Moritani S, Ioffe OB, Sagae S, Dahmoush L, Silverberg SG, Hattori T.

Int J Gynecol Pathol. 2002 Apr;21(2):125-33.

PMID:
11917221
10.

Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions.

Little L, Stewart CJ.

Mod Pathol. 2010 Apr;23(4):611-8. doi: 10.1038/modpathol.2009.178. Epub 2010 Jan 8.

13.

Mesonephric hyperplasia of the uterine cervix: a clinicopathologic study of 51 cases.

Seidman JD, Tavassoli FA.

Int J Gynecol Pathol. 1995 Oct;14(4):293-9.

PMID:
8598330
14.
15.

Diffuse laminar endocervical glandular hyperplasia: a case report.

Dainty LA, Krivak TC, Webb JC, Zahn CM, Elkas JC, Chernofsky MR, Rose GS, Maxwell GL.

Int J Gynecol Cancer. 2009 Aug;19(6):1091-3. doi: 10.1111/IGC.0b013e3181a839d3.

PMID:
19820374
16.

Florid mesonephric hyperplasia of the cervix: a report of a case with review of the literature.

Ayroud Y, Gelfand MM, Ferenczy A.

Int J Gynecol Pathol. 1985;4(3):245-54.

PMID:
2414240
18.

Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype.

Mikami Y, Hata S, Melamed J, Fujiwara K, Manabe T.

Histopathology. 2001 Oct;39(4):364-72.

PMID:
11683936
20.

Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases.

Ferry JA, Scully RE.

Am J Surg Pathol. 1990 Dec;14(12):1100-11.

PMID:
2252101

Supplemental Content

Support Center